Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Enzo Biochem, Inc. (ENZ)

Services-medical Laboratories

https://www.enzo.com

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

60 EXECUTIVE BLVD
FARMINGDALE, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/30/1980

Market Cap

56,603,470

Shares Outstanding

50,490,000

Weighted SO

50,489,771

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

FONR --.--%

BNR --.--%

SERA --.--%

OLK --.--%

LMDX --.--%

GTH --.--%

PMD --.--%

DRIO --.--%

CSTL --.--%

Beta

0.7600

Last Div

0.0000

Range

0.99-1.68

Chg

-0.0100

Avg Vol

121319

Mkt Cap

56603470

Exch

NYSE

Country

US

Phone

212 583 0100

DCF Diff

2.2611

DCF

-1.1211

Div Yield

0.0000

P/S

11.9897

EV Multiple

0.1945

P/FV

0.8161

Div Yield %

0.0000

P/E

1.2594

PEG

-0.0072

Payout

0.0000

Current Ratio

3.4961

Quick Ratio

3.1580

Cash Ratio

2.8692

DSO

304.2311

DIO

148.2427

Op Cycle

452.4738

DPO

30.7658

CCC

421.7079

Gross Margin

-2.8197

Op Margin

1.1756

Pretax Margin

0.7310

Net Margin

9.4753

Eff Tax Rate

-11.7806

ROA

0.4786

ROE

0.6116

ROCE

0.0773

NI/EBT

12.9623

EBT/EBIT

0.6218

EBIT/Rev

1.1756

Debt Ratio

0.0499

D/E

0.0675

LT Debt/Cap

0.0026

Total Debt/Cap

0.0633

Int Coverage

-0.6641

CF/Debt

-9.0510

Equity Multi

1.3540

Rec Turnover

1.1997

Pay Turnover

11.8638

Inv Turnover

2.4622

FA Turnover

0.3027

Asset Turnover

0.0505

OCF/Share

-0.8241

FCF/Share

-0.8435

Cash/Share

1.2137

OCF/Sales

-8.9398

FCF/OCF

1.0236

CF Coverage

-9.0510

ST Coverage

-9.4145

CapEx Coverage

-42.4171

Div&CapEx Cov

-42.4171

P/BV

0.8161

P/B

0.8161

P/S

11.9897

P/E

1.2594

P/FCF

-1.3103

P/OCF

-1.3348

P/CF

-1.3348

PEG

-0.0072

P/S

11.9897

EV Multiple

0.1945

P/FV

0.8161

DPS

0.0000

Latest Headlines (EST)

Benzinga Jun 21, 00:16 Enzon and Viskase Enter into Merger Agreement GlobeNewswire Inc. Jun 21, 00:16 Enzon and Viskase Enter into Merger Agreement GlobeNewswire Inc. Jun 16, 22:40 Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results GlobeNewswire Inc. Oct 29, 23:59 Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend Benzinga Dec 18, 02:46 HEICO, EMCOR Group And 3 Stocks To Watch Heading Into Monday GlobeNewswire Inc. Dec 15, 16:20 ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.07 06/29/1995 11/30/-0001 11/30/-0001 11/30/-0001